Doctor profile · Federal record
Dr. Marwan Salfity, MD
Cardiovascular Disease Physician (CMS: Cardiovascular Disease (Cardiology)) · Omaha, NE
- NPI 1053361824
- Accepts Medicare
- MIPS 84.3 / 100 · 2023
- 41 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
339 N 78Th St
Omaha, NE 681143640
(402) 315-3788
fax (402) 614-1033 - Mailing address
-
Po Box 24223
Omaha, NE 681240223
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- January 20, 2011
- Year of graduation
- 1985 — 41 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Nebraska #20956
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1053361824. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,826
Distinct HCPCS
10
Medicare allowed
$702,079
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,549 | 767 | $119 | |
J2785 |
Injection, regadenoson, 0.1 mg | 884 | 218 | $52 | |
A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose | 762 | 375 | $155 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 616 | 591 | $180 | |
78452 |
Nuclear medicine studies of heart muscle at rest and with stress and spect | 382 | 375 | $403 | |
93015 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 374 | 368 | $58 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 219 | 182 | $13 | |
85610 |
Blood test, clotting time | 214 | 18 | $4 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 210 | 39 | $75 | |
36415 |
Insertion of needle into vein for collection of blood sample | 160 | 126 | $5 |
In context: peer comparison
Among 20 peers in Omaha Cardiovascular Disease Physician, average services per provider: 132. This provider delivers 44× the peer median.Open Payments
Industry payments received
All-time total
$1,422
Transactions
10
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boston Scientific Corporation | 6 | $1,244.76 | |
| Alnylam Pharmaceuticals INC. | 1 | $124.90 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $20.61 | |
| Merck Sharp & Dohme LLC | 1 | $16.32 | |
| Janssen Scientific Affairs, LLC | 1 | $15.63 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
8,709
Patients
2,152
Total drug cost
$1,121,063
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Amlodipine Besylate | Generic | 1,970 | 490 | $14,015 |
| Metoprolol Succinate | Generic | 921 | 235 | $14,330 |
| Losartan Potassium | Generic | 863 | 213 | $10,560 |
| Eliquis (Apixaban) | Brand | 812 | 147 | $732,308 |
| Doxazosin Mesylate | Generic | 680 | 161 | $14,949 |
| Atorvastatin Calcium | Generic | 638 | 171 | $7,287 |
| Carvedilol | Generic | 535 | 135 | $5,007 |
| Amiodarone Hcl | Generic | 436 | 117 | $6,313 |
| Furosemide | Generic | 419 | 129 | $1,814 |
| Xarelto (Rivaroxaban) | Brand | 280 | 60 | $303,480 |
Hospital affiliations
Frequently asked questions
What is Dr. Marwan Salfity's medical specialty?
Dr. Marwan Salfity practices Cardiovascular Disease Physician in Omaha, NE.
Where does Dr. Marwan Salfity practice?
Dr. Marwan Salfity practices at 339 N 78Th St, Omaha, NE 681143640. Office phone: 4023153788.
What is Dr. Marwan Salfity's NPI?
Dr. Marwan Salfity's National Provider Identifier (NPI) is 1053361824, issued by NPPES.
Does Dr. Marwan Salfity accept Medicare assignment?
Yes. Dr. Marwan Salfity accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Marwan Salfity commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Injection, regadenoson, 0.1 mg (HCPCS J2785); Technetium tc-99m sestamibi, diagnostic, per study dose (HCPCS A9500). Source: CMS Medicare Physician & Other Practitioners file.